US Stock MarketDetailed Quotes

PROF Profound Medical

Watchlist
  • 7.860
  • -0.040-0.51%
Trading May 23 10:34 ET
192.01MMarket Cap-6093P/E (TTM)

Profound Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
2.69%1.91M
7.75%7.2M
59.82%2.01M
-15.09%1.73M
-20.89%1.6M
36.36%1.86M
-2.79%6.68M
25.95%1.26M
-19.79%2.04M
-22.92%2.03M
Operating revenue
2.69%1.91M
7.75%7.2M
59.82%2.01M
-15.09%1.73M
-20.89%1.6M
36.36%1.86M
-2.79%6.68M
25.95%1.26M
-19.79%2.04M
-22.92%2.03M
Cost of revenue
-0.93%641K
-23.03%2.82M
36.10%950K
-29.31%668K
-49.31%552K
-30.28%647K
-6.66%3.66M
39.32%698K
-39.03%945K
-22.82%1.09M
Gross profit
4.62%1.27M
45.05%4.38M
89.45%1.06M
-2.75%1.06M
12.18%1.05M
178.21%1.21M
2.34%3.02M
12.47%559K
10.44%1.09M
-23.03%936K
Operating expense
8.69%8.75M
1.15%33M
43.52%9.84M
-18.28%7.62M
-14.09%7.49M
4.18%8.05M
-1.87%32.62M
-32.94%6.86M
8.49%9.32M
14.66%8.71M
Selling and administrative expenses
14.41%4.82M
3.84%18.62M
55.89%5.87M
-8.41%4.21M
-13.83%4.33M
-7.41%4.21M
-0.18%17.93M
-31.81%3.77M
1.12%4.59M
20.21%5.03M
-Selling and marketing expense
15.49%2.43M
11.63%9.45M
74.19%2.92M
-0.77%2.18M
-5.97%2.25M
-4.41%2.11M
10.66%8.47M
-27.31%1.67M
8.06%2.2M
38.54%2.39M
-General and administrative expense
13.34%2.39M
-3.14%9.17M
41.26%2.96M
-15.42%2.02M
-20.97%2.08M
-10.23%2.11M
-8.23%9.47M
-35.03%2.09M
-4.51%2.39M
7.30%2.63M
Research and development costs
2.42%3.93M
-2.13%14.38M
28.42%3.97M
-27.85%3.42M
-14.45%3.16M
20.75%3.84M
-3.84%14.69M
-34.26%3.09M
16.75%4.73M
7.87%3.69M
Operating profit
-9.42%-7.48M
3.33%-28.62M
-39.44%-8.78M
20.33%-6.56M
17.25%-6.44M
6.23%-6.84M
2.27%-29.6M
35.26%-6.3M
-8.24%-8.23M
-21.84%-7.78M
Net non-operating interest income expense
811.72%1.32M
-21.00%726K
113.57%451K
-69.00%1.01M
33.48%303K
133.87%145K
396.45%919K
-825.91%-3.32M
3.27M
886.96%227K
Non-operating interest income
----
104.48%1.64M
139.74%1.37M
-69.00%1.01M
506.67%455K
----
291.71%803K
-3,965.17%-3.44M
14,768.18%3.27M
63.04%75K
Non-operating interest expense
----
342.53%770K
----
----
1,100.00%192K
----
159.70%174K
----
----
-30.43%16K
Total other finance cost
-811.72%-1.32M
150.34%146K
----
----
76.19%-40K
-229.55%-145K
-164.73%-290K
----
----
---168K
Other net income (expense)
-368.11%-807K
-172.51%-1.19M
4,200.00%301K
361.92%1.64M
Gain on sale of security
----
-128.57%-807K
----
----
-172.51%-1.19M
----
40,257.14%2.83M
----
----
361.92%1.64M
Special income (charges)
----
--0
----
----
----
----
---2.52M
----
----
----
-Less:Impairment of capital assets
----
--0
----
----
----
----
--2.52M
----
----
----
Income before tax
7.96%-6.16M
-1.11%-28.7M
1.96%-9.14M
-11.75%-5.55M
-23.77%-7.32M
18.22%-6.69M
7.23%-28.38M
8.55%-9.32M
16.50%-4.96M
15.34%-5.91M
Income tax
-18.75%39K
-144.60%-128K
-211.17%-229K
-47.06%18K
118.75%35K
54.84%48K
173.33%287K
764.52%206K
-34.62%34K
-71.93%16K
Net income
8.04%-6.2M
0.35%-28.57M
6.49%-8.91M
-11.35%-5.56M
-24.03%-7.36M
17.94%-6.74M
6.61%-28.67M
6.24%-9.53M
16.66%-5M
15.80%-5.93M
Net income continuous Operations
8.04%-6.2M
0.35%-28.57M
6.49%-8.91M
-11.35%-5.56M
-24.03%-7.36M
17.94%-6.74M
6.61%-28.67M
6.24%-9.53M
16.66%-5M
15.80%-5.93M
Minority interest income
Net income attributable to the parent company
8.04%-6.2M
0.35%-28.57M
6.49%-8.91M
-11.35%-5.56M
-24.03%-7.36M
17.94%-6.74M
6.61%-28.67M
6.24%-9.53M
16.66%-5M
15.80%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.04%-6.2M
0.35%-28.57M
6.49%-8.91M
-11.35%-5.56M
-24.03%-7.36M
17.94%-6.74M
6.61%-28.67M
6.24%-9.53M
16.66%-5M
15.80%-5.93M
Basic earnings per share
18.75%-0.26
2.17%-1.35
8.70%-0.42
-8.33%-0.26
-25.00%-0.35
20.00%-0.32
8.00%-1.38
6.12%-0.46
17.24%-0.24
20.00%-0.28
Diluted earnings per share
18.75%-0.26
2.17%-1.35
8.70%-0.42
-8.33%-0.26
-25.00%-0.35
20.00%-0.32
8.00%-1.38
6.12%-0.46
17.24%-0.24
20.00%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 2.69%1.91M7.75%7.2M59.82%2.01M-15.09%1.73M-20.89%1.6M36.36%1.86M-2.79%6.68M25.95%1.26M-19.79%2.04M-22.92%2.03M
Operating revenue 2.69%1.91M7.75%7.2M59.82%2.01M-15.09%1.73M-20.89%1.6M36.36%1.86M-2.79%6.68M25.95%1.26M-19.79%2.04M-22.92%2.03M
Cost of revenue -0.93%641K-23.03%2.82M36.10%950K-29.31%668K-49.31%552K-30.28%647K-6.66%3.66M39.32%698K-39.03%945K-22.82%1.09M
Gross profit 4.62%1.27M45.05%4.38M89.45%1.06M-2.75%1.06M12.18%1.05M178.21%1.21M2.34%3.02M12.47%559K10.44%1.09M-23.03%936K
Operating expense 8.69%8.75M1.15%33M43.52%9.84M-18.28%7.62M-14.09%7.49M4.18%8.05M-1.87%32.62M-32.94%6.86M8.49%9.32M14.66%8.71M
Selling and administrative expenses 14.41%4.82M3.84%18.62M55.89%5.87M-8.41%4.21M-13.83%4.33M-7.41%4.21M-0.18%17.93M-31.81%3.77M1.12%4.59M20.21%5.03M
-Selling and marketing expense 15.49%2.43M11.63%9.45M74.19%2.92M-0.77%2.18M-5.97%2.25M-4.41%2.11M10.66%8.47M-27.31%1.67M8.06%2.2M38.54%2.39M
-General and administrative expense 13.34%2.39M-3.14%9.17M41.26%2.96M-15.42%2.02M-20.97%2.08M-10.23%2.11M-8.23%9.47M-35.03%2.09M-4.51%2.39M7.30%2.63M
Research and development costs 2.42%3.93M-2.13%14.38M28.42%3.97M-27.85%3.42M-14.45%3.16M20.75%3.84M-3.84%14.69M-34.26%3.09M16.75%4.73M7.87%3.69M
Operating profit -9.42%-7.48M3.33%-28.62M-39.44%-8.78M20.33%-6.56M17.25%-6.44M6.23%-6.84M2.27%-29.6M35.26%-6.3M-8.24%-8.23M-21.84%-7.78M
Net non-operating interest income expense 811.72%1.32M-21.00%726K113.57%451K-69.00%1.01M33.48%303K133.87%145K396.45%919K-825.91%-3.32M3.27M886.96%227K
Non-operating interest income ----104.48%1.64M139.74%1.37M-69.00%1.01M506.67%455K----291.71%803K-3,965.17%-3.44M14,768.18%3.27M63.04%75K
Non-operating interest expense ----342.53%770K--------1,100.00%192K----159.70%174K---------30.43%16K
Total other finance cost -811.72%-1.32M150.34%146K--------76.19%-40K-229.55%-145K-164.73%-290K-----------168K
Other net income (expense) -368.11%-807K-172.51%-1.19M4,200.00%301K361.92%1.64M
Gain on sale of security -----128.57%-807K---------172.51%-1.19M----40,257.14%2.83M--------361.92%1.64M
Special income (charges) ------0-------------------2.52M------------
-Less:Impairment of capital assets ------0------------------2.52M------------
Income before tax 7.96%-6.16M-1.11%-28.7M1.96%-9.14M-11.75%-5.55M-23.77%-7.32M18.22%-6.69M7.23%-28.38M8.55%-9.32M16.50%-4.96M15.34%-5.91M
Income tax -18.75%39K-144.60%-128K-211.17%-229K-47.06%18K118.75%35K54.84%48K173.33%287K764.52%206K-34.62%34K-71.93%16K
Net income 8.04%-6.2M0.35%-28.57M6.49%-8.91M-11.35%-5.56M-24.03%-7.36M17.94%-6.74M6.61%-28.67M6.24%-9.53M16.66%-5M15.80%-5.93M
Net income continuous Operations 8.04%-6.2M0.35%-28.57M6.49%-8.91M-11.35%-5.56M-24.03%-7.36M17.94%-6.74M6.61%-28.67M6.24%-9.53M16.66%-5M15.80%-5.93M
Minority interest income
Net income attributable to the parent company 8.04%-6.2M0.35%-28.57M6.49%-8.91M-11.35%-5.56M-24.03%-7.36M17.94%-6.74M6.61%-28.67M6.24%-9.53M16.66%-5M15.80%-5.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.04%-6.2M0.35%-28.57M6.49%-8.91M-11.35%-5.56M-24.03%-7.36M17.94%-6.74M6.61%-28.67M6.24%-9.53M16.66%-5M15.80%-5.93M
Basic earnings per share 18.75%-0.262.17%-1.358.70%-0.42-8.33%-0.26-25.00%-0.3520.00%-0.328.00%-1.386.12%-0.4617.24%-0.2420.00%-0.28
Diluted earnings per share 18.75%-0.262.17%-1.358.70%-0.42-8.33%-0.26-25.00%-0.3520.00%-0.328.00%-1.386.12%-0.4617.24%-0.2420.00%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg